cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
180 Life Sciences Corp
9 own
10 watching
Current Price
$4.97
$-0.06
(-1.19%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1.03M
52-Week High
52-Week High
17.75000
52-Week Low
52-Week Low
1.16000
Average Volume
Average Volume
1.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1.03M
icon52-Week High17.75000
icon52-Week Low1.16000
iconAverage Volume1.02M
iconDividend Yield--
iconP/E Ratio--
What does the 180 Life Sciences Corp do?
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. The Company is primary focused on program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). The Company has three product development platforms: Anti-TNF platform, SCAs platform and a7nAChR platform. Anti-TNF platform is focused on fibrosis and anti-tumor necrosis factor (anti-TNF). SCAs platform is focused on drugs which are synthetic cannabidiol (CBD) or cannabigerol (CBG) analogues (SCAs). a7nAChR platform is focused on alpha 7 nicotinic acetylcholine receptor (a7nAChR). It is conducting clinical trials only for certain indications under the anti-TNF platform. The Company is undertaking preclinical research and development activities for the SCA platform.
Read More
How much money does 180 Life Sciences Corp make?
News & Events about 180 Life Sciences Corp.
Globe Newswire
1 year ago
Priced At-The-Market Under Nasdaq RulesPALO ALTO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, 180 Life Sciences or the Company), a clinical-stage biotechnology company, today announced that it has entered into a definitive agreement with a single healthcare-...
Globe Newswire
1 year ago
PALO ALTO, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the Company), today announced that Professor Jagdeep Nanchahal has been selected to present at the Gordon Research Conference on Physiological and Disease Relevance and Underlying ...
Globe Newswire
1 year ago
PALO ALTO, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the Company), today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a Notice of Allowance for United States (US) patent application number 17/...
Globe Newswire
1 year ago
PALO ALTO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the Company), today announced the publication of a review entitled Treatments for early stage Dupuytrens disease: an evidence-based approach in The Journal of Hand Surgery (European ...
Globe Newswire
1 year ago
PALO ALTO, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the Company), today announced that the Company has engaged Kinexum, a strategic advisory firm, to support the Company in submitting a Marketing Authorisation Application (MAA) for ...
Frequently Asked Questions
Frequently Asked Questions
What is 180 Life Sciences Corp share price today?
plus_minus_icon
Can Indians buy 180 Life Sciences Corp shares?
plus_minus_icon
How can I buy 180 Life Sciences Corp shares from India?
plus_minus_icon
Can Fractional shares of 180 Life Sciences Corp be purchased?
plus_minus_icon
What are the documents required to start investing in 180 Life Sciences Corp stocks?
plus_minus_icon
What is today’s traded volume of 180 Life Sciences Corp?
plus_minus_icon
What is today’s market capitalisation of 180 Life Sciences Corp?
plus_minus_icon
What is the 52-Week High and Low Range of 180 Life Sciences Corp?
plus_minus_icon
What percentage is 180 Life Sciences Corp down from its 52-Week High?
plus_minus_icon
What percentage is 180 Life Sciences Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$4.97
$-0.06
(-1.19%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00